AMLX

Amylyx Pharmaceuticals
$19.49
+$1.08 (+5.87%)Jul 27, 2026
2.9FairMoatMint rating

MoatMint rates Amylyx Pharmaceuticals (AMLX) 2.9 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.5 out of 10.

Key metrics

The numbers that frame AMLX today
Market cap
$2.17B
P/E (TTM)
-14.4
EV / FCF
-16.1
ROIC
-158.9%
Div yield
0%
Debt / equity
0.0
52wk Low
$7.48
52wk High
$19.60

AMLX stock rating

How AMLX scores on quality, value, growth, momentum and financial health
2.9out of 10
Fair overallNeutral business, expensive priceTop 71% of ~5,000 US stocks
QualityPoor0.5/10
GrowthPoor1.0/10
MomentumGreat8.6/10
ValueFair2.6/10
Financial HealthGood7.1/10

Growth

Revenue and earnings trend for AMLX
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about AMLX
Is Amylyx Pharmaceuticals a good buy?
Hold. Amylyx Pharmaceuticals has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Amylyx Pharmaceuticals is selling at a high price.
What is the market capitalization of AMLX?
Amylyx Pharmaceuticals's market capitalization is $2.17B.
What is the P/E ratio for AMLX stock?
Amylyx Pharmaceuticals's current P/E ratio is -14.4.
What is the 52-week high for AMLX stock?
The 52-week high for Amylyx Pharmaceuticals is $19.60. The current close of $19.49 is 0.6% below that high.
What is the 52-week low for AMLX stock?
The 52-week low for Amylyx Pharmaceuticals is $7.48. The current close of $19.49 is 160.6% above that low.
Does AMLX stock pay dividends?
Amylyx Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AMLX?
Amylyx Pharmaceuticals's Debt / Equity ratio is 0.02.